486 related articles for article (PubMed ID: 20450445)
1. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
Johnson DA; Levy BH
Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
[TBL] [Abstract][Full Text] [Related]
2. Lower esophageal sphincter injections for the treatment of gastroesophageal reflux disease.
Watson TJ; Peters JH
Thorac Surg Clin; 2005 Aug; 15(3):405-15. PubMed ID: 16104131
[TBL] [Abstract][Full Text] [Related]
3. Emerging drugs for gastroesophageal reflux disease.
Boeckxstaens GE
Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
[TBL] [Abstract][Full Text] [Related]
4. Treatment of gastro-esophageal reflux disease: the new kids to block.
Blondeau K
Neurogastroenterol Motil; 2010 Aug; 22(8):836-40. PubMed ID: 20663054
[TBL] [Abstract][Full Text] [Related]
5. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors.
Hershcovici T; Fass R
Curr Opin Gastroenterol; 2010 Jul; 26(4):367-78. PubMed ID: 20571388
[TBL] [Abstract][Full Text] [Related]
6. Reflux inhibitors: a new approach for GERD?
Boeckxstaens GE
Curr Opin Pharmacol; 2008 Dec; 8(6):685-9. PubMed ID: 18771751
[TBL] [Abstract][Full Text] [Related]
7. GABAB receptors as drug targets to treat gastroesophageal reflux disease.
Lehmann A
Pharmacol Ther; 2009 Jun; 122(3):239-45. PubMed ID: 19303900
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of GORD. Emerging therapeutic targets and concepts.
Zerbib F
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):937-46. PubMed ID: 21126705
[TBL] [Abstract][Full Text] [Related]
9. Evolving pharmacological approaches in gastroesophageal reflux disease.
Altan E; Blondeau K; Pauwels A; Farré R; Tack J
Expert Opin Emerg Drugs; 2012 Sep; 17(3):347-59. PubMed ID: 22834684
[TBL] [Abstract][Full Text] [Related]
10. New pharmacological agents for the treatment of gastroesophageal reflux disease.
Vakil N
Rev Gastroenterol Disord; 2008; 8(2):117-22. PubMed ID: 18641594
[TBL] [Abstract][Full Text] [Related]
11. Lesogaberan, a GABA(B) agonist for the potential treatment of gastroesophageal reflux disease.
Bredenoord AJ
IDrugs; 2009 Sep; 12(9):576-84. PubMed ID: 19697277
[TBL] [Abstract][Full Text] [Related]
12. Novel treatments of GERD: focus on the lower esophageal sphincter.
Lehmann A
Eur Rev Med Pharmacol Sci; 2008 Aug; 12 Suppl 1():103-10. PubMed ID: 18924449
[TBL] [Abstract][Full Text] [Related]
13. New therapies for gastroesophageal reflux disease.
Bredenoord AJ
Minerva Gastroenterol Dietol; 2010 Jun; 56(2):129-38. PubMed ID: 20485251
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
15. A novel reflux inhibitor lesogaberan (AZD3355) as add-on treatment in patients with GORD with persistent reflux symptoms despite proton pump inhibitor therapy: a randomised placebo-controlled trial.
Boeckxstaens GE; Beaumont H; Hatlebakk JG; Silberg DG; Björck K; Karlsson M; Denison H
Gut; 2011 Sep; 60(9):1182-8. PubMed ID: 21402616
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological management of GERD: where does it stand now?
Hershcovici T; Fass R
Trends Pharmacol Sci; 2011 Apr; 32(4):258-64. PubMed ID: 21429600
[TBL] [Abstract][Full Text] [Related]
17. An algorithm for diagnosis and treatment of refractory GERD.
Hershcovici T; Fass R
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):923-36. PubMed ID: 21126704
[TBL] [Abstract][Full Text] [Related]
18. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
Beaumont H; Boeckxstaens GE
Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
[TBL] [Abstract][Full Text] [Related]
19. Medical treatments of GERD: the old and new.
Vela MF
Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
[TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: arbaclofen placarbil in gastro-oesophageal reflux disease--insights into study design for transient lower sphincter relaxation inhibitors.
Vakil NB; Huff FJ; Cundy KC
Aliment Pharmacol Ther; 2013 Jul; 38(2):107-17. PubMed ID: 23721547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
